Agree totally.
The issue is whether the company recognizes the damage the IPO caused and tries to address it or just buries their collective heads in the sand and hopes everyone forgets about it.
If its the latter and some of the recent comments coming from the Chairman IMO suggest this is the case the company is going to underperform for another 12 months at least.
- Forums
- ASX - By Stock
- BIO
- Ann: FY23 Trading Update
Ann: FY23 Trading Update, page-6
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
61.0¢ |
Change
-0.035(5.43%) |
Mkt cap ! $133.6M |
Open | High | Low | Value | Volume |
64.0¢ | 65.0¢ | 61.0¢ | $304.0K | 488.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 61.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
61.5¢ | 4100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65679 | 0.610 |
5 | 27011 | 0.605 |
12 | 120025 | 0.600 |
1 | 8386 | 0.595 |
2 | 15364 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.615 | 4100 | 1 |
0.620 | 3644 | 1 |
0.625 | 22882 | 2 |
0.630 | 45087 | 3 |
0.640 | 4500 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BIO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online